CLINICAL TRIAL article

Front. Surg.

Sec. Genitourinary Surgery and Interventions

Volume 12 - 2025 | doi: 10.3389/fsurg.2025.1563801

The SHA.LIN Renal Stone Scoring System for Predicting Stone-free Status and Postoperative Outcomes after Percutaneous Nephrolithotomy

Provisionally accepted
  • 1School of Medicine, Shihezi University, Shihezi, China
  • 2Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China
  • 3Department of Urology, First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, Xinjiang Uyghur Region, China

The final, formatted version of the article will be published soon.

Objective: To introduce a novel renal stone scoring system (SHA.LIN) for percutaneous nephrolithotomy (PCNL) and to compare the predictive power of the SHA.LIN scoring system versus the Guy's stone score and S.T.O.N.E. scoring system for postoperative outcomes. Methods: Six reproducible parameters available from preoperative computed tomography (CT) data were measured: stone burden (S), hydronephrosis (H), anatomical distribution (A), length of tract (L), indicator of CT (I), and number of involved calyces (N). Data from patients who underwent PCNL between May 2019 and January 2023 were retrospectively reviewed. Correlations between scores from the 3 systems (i.e., SHA.LIN, STONE, and Guy's) and stone-free status (SFS), hemoglobin change, estimated blood loss (EBL), operative time (OT), and postoperative length of hospital stay (PLOS) were evaluated using standard statistical methods.The overall stone-free rate was 69.7% (248/356), and complications occurred in 111 (30.9%) patients. Patients were divided into 2 groups (stone-free vs. non-stone-free), with median (IQR) scores as follows: Guy's, 2 (1-2) vs. 3 (2-3); S.T.O.N.E., 6 (6-8) vs. 8 (7-9.5); and SHA.LIN, 7 (7-9) vs. 11 (10-12.5), respectively (p < 0.001 for all). Univariate regression analysis revealed that the three scoring systems were significantly associated with SFS and OT, although none were significantly correlated with PLOS. EBL and hemoglobin change were significantly correlated with the SHA.LIN score. Multivariate regression analysis revealed that the three scoring systems were significantly associated with SFS. EBL and hemoglobin change were significantly correlated with the SHA.LIN score. Receiver operating characteristic (ROC) curve analysis revealed that the three scoring systems demonstrated comparable predictive accuracy for SFS and complications, with SHA.LIN having the highest area under the ROC curve (AUC) (0.852 and 0.774, respectively). Analysis of the respective AUCs revealed that the SHA.LIN score more accurately predicted EBL (AUC 0.807) than the other 2 scoring systems. Conclusion: The SHA.LIN scoring system accurately predicted postoperative outcomes of PCNL and demonstrated potential as an adjuvant tool for surgical planning. The three scoring systems demonstrated strong associations with SFS, in addition, the SHA.LIN score was also significantly associated with the risk of surgical bleeding.

Keywords: Urology, percutaneous nephrolithotomy (PCNL), Scoring system, Stone clearance, complications

Received: 18 Mar 2025; Accepted: 03 Jun 2025.

Copyright: © 2025 Jia, Wang, Wang, Wang, Li, Wang, Liu and Zeng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Kai Zeng, Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, Hubei Province, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.